Xconomy Features Celgene-GNS REFS License, Investment Deal
Celgene has made a second investment in GNS Healthcare and is tapping into the firm’s data analytics software to boost Celgene’s drug discovery and development efforts. Read the full story here.
MS News Today Features GNS ‘Efficacy to Effectiveness’ Solution
GNS Healthcare is presenting a data-driven causal machine learning solution, called Efficacy to Effectiveness, designed to predict how potential therapies will actually perform in distinct populations. Read the complete story here.
WSJ Pro Venture Capital Coverage of Horizon Investment in GNS Highlights Application of Precision Medicine to Population Health
Health insurers that have struggled to curb rates of chronic illnesses are turning for help to innovative data-analysis startups Read the complete story here.
Health Data Management Spotlights GNS Medication Adherence Program With OmedaRx
Medication management has evolved from intuition-based treatments to population health, which emerged in the mid-1990s with a top-down, rules-based approach that treats individuals as hypotheticals, says Colin Hill, chairman and CEO of GNS Healthcare. But traditional methods to determine which patients to reach out to don’t target people who are at high risk of negative […]
Big Data Analytics Research Projects Target Cancer, Genomics
Several recently announced collaborations between academic research institutions and big data analytics vendors powering advanced discovery technologies will bring the power of big data to new studies that may have significant impacts on future therapies and treatments. With oncology and genomics in the spotlight, personalized medicine is poised to take a leap forward as researchers […]
GNS Use of Machine Learning to Match Health Interventions to Individuals Featured by STAT
Health insurers are scooping up huge quantities of personal information in a bid to figure out when you’re likely to get sick —and to design interventions to keep you healthy. Read the full story here.
MobiHealthNews: GNS Healthcare raises $10M for precision medicine analytics
Cambridge, Massachusetts-based GNS Healthcare, which has developed an analytics tool for precision medicine and population health, raised $10 million from Celgene Corporation, Alexandria Real Estate Equities, and Gi Global Health Fund. Existing investors Cambia Health Solutions, Heritage Provider Network, and Mitsui USA, the US subsidiary of Japan’s Mitsui & Co, also participated. This brings the company’s total funding […]
GNS Healthcare Secures $10M Series C Financing to Accelerate Development of New, Data-Driven Solutions at the Intersection of Precision Medicine and Population Health
New Investors Celgene Corporation, Alexandria Real Estate Equities, and Gi Global Health Fund LP Join Cambia Health Solutions, Heritage Provider Network, Mitsui CAMBRIDGE, Mass. – Dec. 8, 2015 – GNS Healthcare (GNS), a leading precision medicine company that applies causal machine learning technology to match health interventions to individual patients and discover new target intervention pathways, […]
PharmiWeb.com: New Data at ASH 2015 from the Multiple Myeloma Research Foundation
The Multiple Myeloma Research Foundation (MMRF) is presenting today new data from the MMRF CoMMpass StudySM – the most comprehensive long-term genomic study ever conducted in myeloma and one that may significantly advance the understanding of multiple myeloma. The data provide significant insights into the genetics of multiple myeloma and the potential association to patient […]
Modern Healthcare: The newest new thing: Obama’s precision medicine initiative – GNS CEO quoted
“Delivering on precision medicine’s promise is the culmination of many previous technological and policy efforts”, noted Colin Hill, co-founder and CEO of GNS Healthcare, a company specializing in precision analytics. Read the complete article here…